搜索
市场行情
自选
新闻
分析
交易工具
选股器
扫码下载
一键诊股 让投资更聪明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登录
免费注册
搜索
免费注册
市场行情
/
股票
/
医药与医学研究
/
药品
/
rytm
/
财务摘要
Rhythm Pharmaceuticals Inc
RYTM
添加自选
98.770
USD
-0.250
-0.25%
交易中 09/18, 15:09(美东)
6.80B
总市值
亏损
市盈率 TTM
Rhythm Pharmaceuticals Inc
98.770
-0.250
-0.25%
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
概览
新闻分析
财务
股票评分
技术分析
预测
持股情况
股息
公司资料
财务摘要
利润表
资产负债表
现金流量表
公司收入
财报
公司估值
风险评估
RYTM 财务数据
通过专为投资者打造的一站式数据看板,全面查看 Rhythm Pharmaceuticals Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。
关键财务比率
总市值
6.80B
股息TTM
0.00
市盈率 TTM
-31.50
每股收益TTM
-3.14
营业收入
189.76M
净利润
-264.57M
净资产收益率
-293.04%
总资产收益率
-48.90%
Rhythm Pharmaceuticals Inc 财报日历
最新发布
8月 4, 2026
每股收益 / 预测值
-0.73
/-0.82
营业收入 / 预测值
71.25M
/67.28M
财务报表摘要
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
财务指标
每股收益
2.55%
-0.73
-3.58%
-0.83
-0.76%
-0.73
-11.52%
-0.82
-36.96%
-0.75
65.71%
-0.81
-3.07%
-0.72
3.74%
-0.73
33.02%
-0.55
-155.46%
-2.35
6.79%
-0.70
--
-0.76
--
-0.82
--
-0.92
--
-0.75
--
-2.73
--
--
--
--
--
--
--
--
营业收入
46.91%
71.25M
83.81%
60.11M
36.87%
57.25M
54.28%
51.30M
66.80%
48.50M
25.94%
32.70M
72.61%
41.83M
47.76%
33.25M
51.28%
29.08M
126.41%
25.97M
175.70%
24.23M
425.30%
22.50M
112.01%
19.22M
665.62%
11.47M
383.76%
8.79M
316.73%
4.28M
3208.76%
9.07M
4180.00%
1.50M
--
1.82M
--
1.03M
净利润
-4.96%
-50.36M
-11.65%
-56.74M
-9.42%
-48.84M
-20.70%
-54.28M
-42.96%
-47.98M
64.05%
-50.82M
-7.20%
-44.63M
-1.83%
-44.97M
28.14%
-33.56M
-170.94%
-141.37M
2.02%
-41.63M
-8.08%
-44.16M
-3.78%
-46.70M
1.11%
-52.18M
0.87%
-42.49M
-16.39%
-40.86M
-27.16%
-45.00M
-220.60%
-52.76M
-22.84%
-42.87M
-3.81%
-35.11M
利润率
28.04%
-69.19%
38.85%
-92.56%
19.83%
-82.97%
21.42%
-103.13%
13.34%
-96.14%
72.20%
-151.35%
39.76%
-103.50%
33.12%
-131.25%
54.34%
-110.95%
-19.67%
-544.43%
64.46%
-171.80%
--
-196.25%
--
-242.98%
--
-454.96%
--
-483.42%
--
-933.63%
--
--
--
--
--
--
--
--
毛利率
-70.06%
26.52%
-0.85%
88.09%
0.73%
91.61%
0.90%
89.28%
-1.44%
88.57%
-0.39%
88.85%
4.95%
90.95%
-0.89%
88.49%
1.70%
89.87%
1.80%
89.19%
-1.86%
86.66%
--
89.28%
--
88.37%
--
87.61%
--
88.30%
--
92.56%
--
--
--
--
--
--
--
--
资产负债率
-17.62%
24.26%
-13.42%
24.52%
-19.52%
22.53%
-28.45%
21.50%
3.79%
29.46%
-31.77%
28.32%
-12.24%
27.99%
1.65%
30.05%
10.86%
28.38%
85.11%
41.51%
60.94%
31.90%
--
29.56%
--
25.60%
--
22.43%
--
19.82%
--
18.73%
--
--
--
--
--
--
--
--
利润表
营业收入
46.91%
71.25M
83.81%
60.11M
36.87%
57.25M
54.28%
51.30M
66.80%
48.50M
25.94%
32.70M
72.61%
41.83M
47.76%
33.25M
51.28%
29.08M
126.41%
25.97M
175.70%
24.23M
425.30%
22.50M
112.01%
19.22M
665.62%
11.47M
383.76%
8.79M
316.73%
4.28M
3208.76%
9.07M
4180.00%
1.50M
--
1.82M
--
1.03M
营业利润
-7.19%
-48.55M
-11.40%
-52.36M
-14.08%
-47.06M
-19.98%
-52.65M
-11.90%
-45.30M
66.40%
-47.00M
0.02%
-41.26M
0.15%
-43.88M
13.14%
-40.48M
-166.29%
-139.89M
1.99%
-41.27M
-11.93%
-43.95M
-3.34%
-46.60M
0.30%
-52.53M
17.43%
-42.10M
11.24%
-39.27M
-11.54%
-45.10M
-53.18%
-52.69M
-45.38%
-50.99M
-29.04%
-44.24M
净利润
-4.96%
-50.36M
-11.65%
-56.74M
-9.42%
-48.84M
-20.70%
-54.28M
-42.96%
-47.98M
64.05%
-50.82M
-7.20%
-44.63M
-1.83%
-44.97M
28.14%
-33.56M
-170.94%
-141.37M
2.02%
-41.63M
-8.08%
-44.16M
-3.78%
-46.70M
1.11%
-52.18M
0.87%
-42.49M
-16.39%
-40.86M
-27.16%
-45.00M
-220.60%
-52.76M
-22.84%
-42.87M
-3.81%
-35.11M
资产负债表
流动资产
18.27%
426.56M
16.46%
430.09M
24.78%
466.92M
45.38%
494.80M
0.93%
360.68M
56.64%
369.29M
21.39%
374.20M
3.38%
340.34M
25.89%
357.37M
-25.83%
235.75M
-12.98%
308.27M
-9.03%
329.20M
13.86%
283.88M
25.41%
317.84M
14.87%
354.24M
7.82%
361.87M
-34.12%
249.33M
-38.50%
253.45M
69.75%
308.39M
59.89%
335.64M
流动负债总额
-4.53%
123.59M
-7.71%
103.20M
-8.29%
105.94M
6.83%
104.27M
136.57%
129.46M
106.47%
111.82M
109.26%
115.52M
94.65%
97.61M
18.70%
54.72M
17.66%
54.16M
38.67%
55.20M
51.50%
50.14M
3.44%
46.10M
-2.63%
46.03M
-8.33%
39.81M
41.04%
33.10M
155.28%
44.57M
180.56%
47.27M
141.34%
43.43M
48.08%
23.47M
总资产
17.31%
437.27M
14.39%
442.32M
22.41%
480.20M
39.42%
506.87M
-2.39%
372.73M
49.50%
386.69M
17.89%
392.27M
2.65%
363.57M
23.20%
381.85M
-25.18%
258.65M
-13.00%
332.75M
-9.09%
354.20M
11.62%
309.94M
21.37%
345.68M
16.07%
382.48M
9.50%
389.61M
-28.51%
277.68M
-32.54%
284.82M
76.15%
329.52M
65.13%
355.82M
总负债
-8.02%
219.97M
-8.45%
204.70M
-7.71%
210.17M
0.15%
211.19M
18.19%
239.15M
13.46%
223.60M
39.72%
227.72M
34.55%
210.88M
58.51%
202.35M
56.51%
197.07M
37.87%
162.99M
44.55%
156.72M
55.59%
127.66M
156.68%
125.92M
160.55%
118.22M
223.06%
108.42M
123.56%
82.05M
18.89%
49.05M
120.84%
45.37M
81.01%
33.56M
总权益
62.67%
217.30M
45.70%
237.62M
64.10%
270.03M
93.64%
295.68M
-25.58%
133.58M
164.84%
163.09M
-3.07%
164.55M
-22.68%
152.70M
-1.53%
179.50M
-71.98%
61.58M
-35.76%
169.76M
-29.77%
197.47M
-6.82%
182.28M
-6.79%
219.76M
-7.00%
264.26M
-12.74%
281.19M
-44.37%
195.63M
-38.11%
235.77M
70.63%
284.15M
63.64%
322.26M
现金流量表
经营净额
60.74%
-9.15M
-9.50%
-44.19M
-34.73%
-25.39M
-5.58%
-26.62M
19.82%
-23.31M
0.96%
-40.35M
35.87%
-18.84M
13.79%
-25.22M
29.24%
-29.08M
-11.83%
-40.74M
13.58%
-29.38M
37.75%
-29.25M
-5.88%
-41.09M
32.07%
-36.43M
15.99%
-34.00M
-17.00%
-46.99M
-21.89%
-38.81M
-59.95%
-53.63M
-38.97%
-40.47M
-48.58%
-40.16M
投资净额
-74.07%
14.01M
129.94%
57.05M
43.44%
30.35M
-171.25%
-246.35M
731.10%
54.03M
-17.43%
24.81M
-6.55%
21.16M
4.36%
-90.82M
-117.77%
-8.56M
62.75%
30.05M
155.52%
22.64M
-139.21%
-94.96M
33.94%
48.19M
-74.54%
18.46M
-662.57%
-40.77M
-163.23%
-39.70M
166.02%
35.98M
149.77%
72.52M
-88.29%
7.25M
79.83%
62.78M
融资净额
-31.05%
-1.17M
-116.62%
-5.40M
-107.69%
-2.95M
7496.35%
189.30M
-100.61%
-889.00K
665.94%
32.50M
1481.84%
38.33M
-96.59%
2.49M
15248.08%
146.18M
3290.23%
4.24M
-86.05%
2.42M
-53.93%
73.04M
-102.57%
-965.00K
-133.33%
-133.00K
17265.00%
17.36M
38293.22%
158.56M
9691.12%
37.50M
-99.76%
399.00K
-76.19%
100.00K
-40.92%
413.00K
营业收入
业务
报告期:
暂无数据
地区
报告期:
暂无数据
常见问题
Rhythm Pharmaceuticals Inc的总收入是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,总收入达到了189.76M(同比变化130.13M)。
Rhythm Pharmaceuticals Inc的流动资产是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,流动资产为466.92M(同比变化24.78)。
Rhythm Pharmaceuticals Inc的总资产是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,Rhythm Pharmaceuticals Inc的总资产为480.20M(同比变化22.41)。
Rhythm Pharmaceuticals Inc的总负债是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,Rhythm Pharmaceuticals Inc的总负债为210.17M(同比变化-7.71)。
Rhythm Pharmaceuticals Inc的总权益是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,Rhythm Pharmaceuticals Inc的总权益为270.03M(同比变化64.10)。
Rhythm Pharmaceuticals Inc的净营业收入是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,Rhythm Pharmaceuticals Inc的净营业收入为-192.02M(同比变化27.68)。
Rhythm Pharmaceuticals Inc的净投资是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,Rhythm Pharmaceuticals Inc的净投资为-137.15M(同比变化-184.71)。
Rhythm Pharmaceuticals Inc的净融资是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,Rhythm Pharmaceuticals Inc的净融资为217.96M(同比变化13.97)。
Rhythm Pharmaceuticals Inc的每股收益(EPS)是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,每股收益(EPS)为-3.11(同比变化28.37)。
Rhythm Pharmaceuticals Inc的净利润是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,净利润为-201.92M(同比变化23.68)。
Rhythm Pharmaceuticals Inc的净利润率是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,净利润率为-103.57(同比变化48.28)。
Rhythm Pharmaceuticals Inc的债务与资产比率是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,债务与资产比率为22.53(同比变化-19.52)。
Rhythm Pharmaceuticals Inc的股东权益回报率(ROE)是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,股东权益回报率(ROE)为-251.14(同比变化9.12)。
Rhythm Pharmaceuticals Inc的资产回报率(ROA)是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,资产回报率(ROA)为-45.05(同比变化37.33)。
Rhythm Pharmaceuticals Inc的营业利润是多少?
根据Rhythm Pharmaceuticals Inc的FY2025财报,营业利润为-192.02M(同比变化27.68)。